NY Life Sciences R&D Credit

NY Life Sciences R&D Credit

Funds New York life sciences companies with tax credits that support innovation with high patient impact potential.

Eligibility · United States · US-NY

The New York Life Sciences R&D Credit is a state-level tax incentive designed to reduce the effective cost of research and development activities for qualifying life sciences companies operating in New York. Administered jointly by Empire State Development (ESD) and the New York State Department of Taxation and Finance (DTF), the program targets new or early-stage life sciences companies — biotech and medtech — that are investing in New York-based R&D operations. The structured record assigns award values between $1,000 and $500,000 with a median near $150,000, covering projects at TRL 3–7 from proof-of-concept through validated pilot systems. Applicants must be for-profit entities; the credit is restricted to life sciences and biotech sectors.

Eligibility requires the company to qualify as a 'new life sciences company' under New York criteria, which typically involves being newly established in the state and committing to New York R&D expenditures. ESD plays a certification role consistent with its broader Excelsior and sector-specific programs, while DTF processes the actual tax credit claim. The refundable or partially refundable structure — typical of New York life sciences incentives — enables pre-profitable companies to access cash benefit rather than merely a future offset against income taxes. This makes the instrument particularly relevant for biotech and medtech startups in preclinical or early clinical-stage development that do not yet generate taxable income.

Because no raw files were available for this funder (fid: empire-state-development-nys-dtf), this overview is grounded in the structured grant record and in related ESD and DTF raw files from adjacent programs. Companies evaluating this credit should confirm current certification thresholds and credit rates directly with ESD's life sciences division, as program parameters for sector-specific New York credits have been revised periodically. Life sciences companies considering New York as a base of R&D operations should evaluate this credit alongside the Excelsior Jobs Program R&D component and relevant Massachusetts alternatives to compare total incentive value.